1. Home
  2. |Insights
  3. |The COVID-19 Pandemic and Downstream Risk: What Companies Should Do Now to Protect Themselves Against Government Investigations and Enforcement Later

The COVID-19 Pandemic and Downstream Risk: What Companies Should Do Now to Protect Themselves Against Government Investigations and Enforcement Later

Webinar | 04.07.20, 9:00 AM EDT - 10:00 AM EDT

Register

The scale of both the COVID-19 pandemic and the government’s response through the CARES Act presents multiple investigation and compliance risks for companies responding to the constantly evolving crisis. 


Please join us for a wide ranging discussion of what companies can do now to prepare for and mitigate that risk, whether related to their workforce and domestic operations, network infrastructure and online presence, increased corruption risk in international operations, or acceptance of federal assistance under the CARES Act.


For more information, please visit these areas: Investigations, Government Contracts , White Collar and Regulatory Enforcement

Contact

Participants

Insights

Webinar | 12.10.26

The Third-Party Perspective: Protecting Payors’ Interests in Antitrust Investigations

The Trump administration has sharpened its focus on hospital systems as a key driver of rising health care costs, and the DOJ and FTC are actively patrolling for anticompetitive conduct and mergers that contribute to these rising costs. Managed care organizations are a critical source of evidence in these investigations and are likely to receive Civil Investigative Demands (CIDs), be contacted by agency staff, or may consider proactively engaging with antitrust authorities to address competitive concerns in their markets.

View All Insights